Pepsinogen-II 100 bp ins/del gene polymorphism and its elevated circulating levels are associated with gastric cancer, particularly with Helicobacter pylori infection and intestinal metaplasia.

THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION. Acta Pathol Microbiol Scand (1965) 22.65

Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol (1996) 21.37

Estimating the world cancer burden: Globocan 2000. Int J Cancer (2001) 16.92

Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res (1992) 12.77

Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol (2008) 4.44

Cancer mortality in India: a nationally representative survey. Lancet (2012) 4.30

Ethnicity and H. pylori as risk factors for gastric cancer in Malaysia: A prospective case control study. Am J Gastroenterol (2006) 3.14

Cellular localization of the group II pepsinogens in human stomach and duodenum by immunofluorescence. Gastroenterology (1973) 1.82

Usefulness of gastric cancer screening using the serum pepsinogen test method. Am J Gastroenterol (2003) 1.64

Virulence-associated genotypes of Helicobacter pylori: do they explain the African enigma? Am J Gastroenterol (2002) 1.60

Accuracy of screening for gastric cancer using serum pepsinogen concentrations. Gut (1999) 1.60

Chronic gastritis: a clinico-pathological classification. Am J Gastroenterol (1988) 1.56

Helicobacter pylori CagA status associated with gastric cancer incidence rate variability in Costa Rican regions. J Gastroenterol (2006) 1.49

Helicobacter pylori infection in functional dyspepsia. Nat Rev Gastroenterol Hepatol (2013) 1.41

Elevated serum pepsinogen I and II levels differ as risk factors for duodenal ulcer and gastric ulcer. Gastroenterology (1986) 1.16

Can Helicobacter pylori-associated dyspepsia be categorized as functional dyspepsia? J Gastroenterol Hepatol (2011) 1.16

Serum biomarkers provide an accurate method for diagnosis of atrophic gastritis in a general population: The Kalixanda study. Scand J Gastroenterol (2008) 1.14

Non-invasive tests in gastric diseases. Dig Liver Dis (2008) 1.13

Asian consensus report on functional dyspepsia. J Neurogastroenterol Motil (2012) 1.09

Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Virchows Arch (2011) 0.99

Validity of serum pepsinogen I/II ratio for the diagnosis of gastric epithelial dysplasia and intestinal metaplasia during the follow-up of patients at risk for intestinal-type gastric adenocarcinoma. Neoplasia (2004) 0.97

Frequency of Helicobacter pylori and CagA antibody in patients with gastric neoplasms and controls: the Indian enigma. Dig Dis Sci (2008) 0.97

What is the difference between Helicobacter pylori-associated dyspepsia and functional dyspepsia? J Neurogastroenterol Motil (2011) 0.94

Etiology of gastric cancer: what is new? Cancer Epidemiol Biomarkers Prev (2005) 0.92

The Indian enigma of frequent H. pylori infection but infrequent gastric cancer: is the magic key in Indian diet, host's genetic make up, or friendly bug? Am J Gastroenterol (2007) 0.91

The enigma of Helicobacter pylori infection and gastric cancer. Indian J Gastroenterol (2010) 0.90

Association between pepsinogen C gene polymorphism and genetic predisposition to gastric cancer. World J Gastroenterol (2003) 0.90

Pepsinogen C gene product is a possible growth factor during gastric mucosal healing. Biochem Biophys Res Commun (1997) 0.85

Gastric cancer in a Caucasian population: role of pepsinogen C genetic variants. World J Gastroenterol (2006) 0.82

Human pepsinogen C (progastricsin) polymorphism: evidence for a single locus located at 6p21.1-pter. Genomics (1989) 0.82

Genetic polymorphism of cytochrome P450 (CYP) 1A1, CYP1A2, and CYP2E1 genes modulate susceptibility to gastric cancer in patients with Helicobacter pylori infection. Gastric Cancer (2013) 0.81

Association between gastric mucosal glutathione-S-transferase activity, glutathione-S-transferase gene polymorphisms and Helicobacter pylori infection in gastric cancer. Indian J Gastroenterol (2011) 0.81

Association between genetic polymorphism of the pepsinogen C gene and gastric body ulcer: the genetic predisposition is not associated with Helicobacter pylori infection. Gut (1997) 0.80

Serum pepsinogens in gastric cancer screening. Dig Dis Sci (2010) 0.80

[Correlation of pepsinogen C (PGC) gene insertion/deletion polymorphism to PGC protein expression in gastric mucosa and serum]. Ai Zheng (2009) 0.79

A highly informative polymorphism of the pepsinogen C gene detected by polymerase chain reaction. Adv Exp Med Biol (1991) 0.79

Pepsinogen polymorphism in the Indian population and its association with duodenal ulcer. Hum Genet (1997) 0.78

Influence of pepsinogen gene polymorphisms on serum pepsinogen. Ann Hum Genet (1997) 0.77

In-house rapid urease test kit and commercial kit: which is better? Indian J Gastroenterol (1999) 0.77

Serological assessment of gastric intestinal metaplasia and atrophy using pepsinogen-I, pepsinogen-II and gastrin-17 levels in a low incidence area of gastric cancer endemic for H. pylori infection. Trop Gastroenterol (2012) 0.76

Association of microsomal epoxide hydrolase exon 3 Tyr113His and exon 4 His139Arg polymorphisms with gastric cancer in India. Indian J Gastroenterol (2013) 0.76

RFLPs for the human pepsinogen A haplotypes (PGA). Nucleic Acids Res (1988) 0.75

Achalasia Is Associated With eNOS4a4a, iNOS22GA, and nNOS29TT Genotypes: A Case-control Study. J Neurogastroenterol Motil (2015) 0.80